| Primary |
| Basedow's Disease |
43.3% |
| Hyperthyroidism |
14.6% |
| Radioactive Iodine Therapy |
10.2% |
| Thyroid Cancer |
9.9% |
| Isotope Therapy To Thyroid |
4.9% |
| Goitre |
3.7% |
| Thyroid Therapy |
2.4% |
| Toxic Nodular Goitre |
2.3% |
| Thyroid Cancer Metastatic |
1.9% |
| Adjuvant Therapy |
1.5% |
| Atrial Fibrillation |
1.0% |
| Radioisotope Scan |
0.6% |
| Thyroid Neoplasm |
0.6% |
| Diabetes Mellitus |
0.5% |
| Metastases To Lung |
0.5% |
| Radiotherapy |
0.5% |
| Scintigraphy |
0.5% |
| Haematopoietic Stem Cell Mobilisation |
0.3% |
| Premedication |
0.3% |
| Thyroid Adenoma |
0.3% |
|
| Hypothyroidism |
55.4% |
| Acute Myeloid Leukaemia |
4.3% |
| Myelodysplastic Syndrome |
3.9% |
| Thyroid Cancer |
3.5% |
| Hyperparathyroidism |
3.3% |
| Parathyroid Tumour Benign |
3.1% |
| Treatment Failure |
3.1% |
| Abortion Spontaneous |
2.9% |
| Breast Cancer |
2.9% |
| Sialoadenitis |
2.5% |
| Neoplasm Malignant |
2.1% |
| Colon Cancer |
1.9% |
| Hypocalcaemia |
1.9% |
| Chronic Myeloid Leukaemia |
1.8% |
| Hyperthyroidism |
1.4% |
| Malignant Urinary Tract Neoplasm |
1.4% |
| Gastric Cancer |
1.2% |
| Pulmonary Fibrosis |
1.2% |
| Tongue Discolouration |
1.2% |
| Basedow's Disease |
1.0% |
|
| Secondary |
| Radioactive Iodine Therapy |
19.8% |
| Thyroid Cancer |
18.9% |
| Basedow's Disease |
8.5% |
| Haematopoietic Stem Cell Mobilisation |
7.5% |
| Whole Body Scan |
6.6% |
| Hyperthyroidism |
4.7% |
| Thyroid Hormone Replacement Therapy |
4.7% |
| Metastases To Bone |
3.8% |
| Radioisotope Scan |
3.8% |
| Thyroid Cancer Metastatic |
3.8% |
| Tri-iodothyronine Abnormal |
3.8% |
| Goitre |
2.8% |
| Adjuvant Therapy |
1.9% |
| Atrial Fibrillation |
1.9% |
| Scan Thyroid Gland |
1.9% |
| Thyroid Therapy |
1.9% |
| Blood Thyroid Stimulating Hormone Increased |
0.9% |
| Drug Use For Unknown Indication |
0.9% |
| Hormone Suppression Therapy |
0.9% |
| Iodine Uptake |
0.9% |
|
| Chronic Myeloid Leukaemia |
13.4% |
| Treatment Failure |
11.9% |
| Refractory Cytopenia With Multilineage Dysplasia |
9.0% |
| Acute Promyelocytic Leukaemia |
6.0% |
| Pancytopenia |
6.0% |
| White Blood Cell Count Decreased |
6.0% |
| Hyperthyroidism |
4.5% |
| Metastasis |
4.5% |
| Parathyroid Tumour Benign |
4.5% |
| Subarachnoid Haemorrhage |
4.5% |
| Vocal Cord Paresis |
4.5% |
| Dacryostenosis Acquired |
3.0% |
| Graft Versus Host Disease |
3.0% |
| Hypothyroidism |
3.0% |
| Intra-uterine Death |
3.0% |
| Premature Labour |
3.0% |
| Prothrombin Time Prolonged |
3.0% |
| Thyroid Cancer |
3.0% |
| Thyroid Disorder |
3.0% |
| Acute Lymphocytic Leukaemia |
1.5% |
|
| Concomitant |
| Nuclear Magnetic Resonance Imaging |
54.5% |
| Angiogram |
45.5% |
|
|
